Ono Pharmaceutical partners with Phylo to embed agentic AI with every discovery scientist – BioSpectrum Asia

Ono Pharmaceutical has entered a partnership with Phylo to integrate agentic AI technology into its drug discovery operations, enabling each discovery scientist to utilize AI tools in their research. The collaboration aims to enhance productivity and accelerate the pharmaceutical development process through widespread AI adoption across the company’s scientific workforce.

Read Full Article →